Aytu Biopharma, Inc.
AYTU
$2.39
$0.0954.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.91% | 1.44% | 0.51% | 1.24% | 1.18% |
| Total Receivables | 41.03% | 9.69% | -1.94% | -21.08% | 1.78% |
| Inventory | -0.24% | -5.57% | -7.08% | -4.24% | 1.48% |
| Prepaid Expenses | 20.90% | 7.59% | 1.72% | -22.27% | -10.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -24.76% |
| Total Current Assets | 15.00% | 3.81% | -1.86% | -12.99% | -0.34% |
|
|
|||||
| Total Current Assets | 15.00% | 3.81% | -1.86% | -12.99% | -0.34% |
| Net Property, Plant & Equipment | -2.18% | -11.63% | 25.95% | -44.90% | -15.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.50% | -2.44% | -2.38% | -3.01% | -2.92% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.21% | -22.78% | -11.57% | 150.73% | -1.98% |
| Total Assets | 6.86% | 0.34% | -1.92% | -8.36% | -1.82% |
|
|
|||||
| Total Accounts Payable | 2.92% | -13.42% | 29.43% | -0.33% | 0.02% |
| Total Accrued Expenses | -10.52% | 0.91% | -13.71% | -0.57% | -2.64% |
| Short-term Debt | 149.95% | -6.04% | 78.29% | 51.49% | 54.09% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.92% | -12.90% | -8.88% | -84.21% | 1,055.40% |
| Total Finance Division Other Current Liabilities | 9.26% | 23.16% | -10.72% | -25.84% | 16.89% |
| Total Other Current Liabilities | 9.26% | 23.16% | -10.72% | -25.84% | 16.89% |
| Total Current Liabilities | 10.40% | 4.56% | -1.57% | -25.64% | 30.38% |
|
|
|||||
| Total Current Liabilities | 10.40% | 4.56% | -1.57% | -25.64% | 30.38% |
| Long-Term Debt | -4.49% | -4.29% | -4.11% | -- | -- |
| Short-term Debt | 149.95% | -6.04% | 78.29% | 51.49% | 54.09% |
| Capital Leases | -9.49% | -3.32% | 98.27% | -26.31% | -7.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.93% | -21.66% | -21.07% | 22.65% | -25.95% |
| Total Liabilities | 4.49% | -0.63% | -4.84% | -7.86% | -0.32% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.04% | 0.18% | 0.45% | 0.23% |
| Retained Earnings | 1.26% | 0.25% | 0.46% | -1.46% | -0.92% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 13.43% | 3.15% | 7.61% | -9.95% | -6.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.43% | 3.15% | 7.61% | -9.95% | -6.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.43% | 3.15% | 7.61% | -9.95% | -6.32% |
|
|
|||||